Evidence map›Paper›PMID 42782902›Full record

ReviewCurrent oncology (Toronto, Ont.)2026

Breast-Ovarian Hereditary Cancer Syndrome: Beyond

Evgeny Imyanitov, Anna Sokolenko

Abstract readReview
In one paragraph

Review in Current oncology (Toronto, Ont.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Evgeny ImyanitovDepartment of Tumor Growth Biology, N.N. Petrov Institute of Oncology, 197758 Saint-Petersburg, Russia.ORCID 0000-0003-4529-7891
Anna SokolenkoDepartment of Tumor Growth Biology, N.N. Petrov Institute of Oncology, 197758 Saint-Petersburg, Russia.ORCID 0000-0001-6304-1609

Funding

Russian Science Foundation 21-75-30015
6 · The paper itself

Abstract

Although

Indexed as

BRCA1 ProteinBRCA2 ProteinHereditary Breast and Ovarian Cancer SyndromeOvarian NeoplasmsFanconi Anemia Complementation Group N ProteinFemaleGenetic Predisposition to DiseaseGenetic TestingGerm-Line MutationHumansBRCA1 ProteinBRCA1 protein, humanBRCA2 ProteinBRCA2 protein, humanFanconi Anemia Complementation Group N Proteinbreast cancergermline pathogenic variantNCCN guidelinesnon-BRCA genesovarian cancer

Identifiers

PMID42782902
PMCPMC13605284

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.